Koroshetz WJ - Search Results

1

Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage.

Polidori MC, Frei B, Rordorf G, Ogilvy CS, Koroshetz WJ, Beal MF. Polidori MC, et al. Among authors: koroshetz wj. Free Radic Biol Med. 1997;23(5):762-7. doi: 10.1016/s0891-5849(97)00053-1. Free Radic Biol Med. 1997. PMID: 9296453 Free article.

2

Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke.

Polidori MC, Frei B, Cherubini A, Nelles G, Rordorf G, Keaney JF Jr, Schwamm L, Mecocci P, Koroshetz WJ, Beal MF. Polidori MC, et al. Among authors: koroshetz wj. Free Radic Biol Med. 1998 Sep;25(4-5):561-7. doi: 10.1016/s0891-5849(98)00085-9. Free Radic Biol Med. 1998. PMID: 9741593 Free article.

3

Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage.

Rordorf G, Koroshetz WJ, Copen WA, Gonzalez G, Yamada K, Schaefer PW, Schwamm LH, Ogilvy CS, Sorensen AG. Rordorf G, et al. Among authors: koroshetz wj. Stroke. 1999 Mar;30(3):599-605. doi: 10.1161/01.str.30.3.599. Stroke. 1999. PMID: 10066858

4

Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome.

Oliveira-Filho J, Ezzeddine MA, Segal AZ, Buonanno FS, Chang Y, Ogilvy CS, Rordorf G, Schwamm LH, Koroshetz WJ, McDonald CT. Oliveira-Filho J, et al. Among authors: koroshetz wj. Neurology. 2001 May 22;56(10):1299-304. doi: 10.1212/wnl.56.10.1299. Neurology. 2001. PMID: 11376177

5

SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage.

Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ. Singhal AB, et al. Among authors: koroshetz wj. Neurology. 2005 Mar 22;64(6):1008-13. doi: 10.1212/01.WNL.0000154523.21633.0E. Neurology. 2005. PMID: 15781818

6

Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.

Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Koroshetz WJ, et al. Ann Neurol. 1997 Feb;41(2):160-5. doi: 10.1002/ana.410410206. Ann Neurol. 1997. PMID: 9029064

7

Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

Beal MF, Hyman BT, Koroshetz W. Beal MF, et al. Trends Neurosci. 1993 Apr;16(4):125-31. doi: 10.1016/0166-2236(93)90117-5. Trends Neurosci. 1993. PMID: 7682343

8

Predictors of mortality in stroke patients admitted to an intensive care unit.

Rordorf G, Koroshetz W, Efird JT, Cramer SC. Rordorf G, et al. Crit Care Med. 2000 May;28(5):1301-5. doi: 10.1097/00003246-200005000-00007. Crit Care Med. 2000. PMID: 10834669

9

Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests.

Topcuoglu MA, Ogilvy CS, Carter BS, Buonanno FS, Koroshetz WJ, Singhal AB. Topcuoglu MA, et al. Among authors: koroshetz wj. J Neurosurg. 2003 Jun;98(6):1235-40. doi: 10.3171/jns.2003.98.6.1235. J Neurosurg. 2003. PMID: 12816270

10

High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study.

Nogueira RG, Bodock MJ, Koroshetz WJ, Topcuoglu MA, Carter BS, Ogilvy CS, Pryor JC, Buonanno FS. Nogueira RG, et al. Among authors: koroshetz wj. Neurocrit Care. 2007;7(3):194-202. doi: 10.1007/s12028-007-0070-4. Neurocrit Care. 2007. PMID: 17901934 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters